Ranbaxy Laboratories Ltd. - Research Center
500359 RANBAXY Group (B) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 14 | Dec ' 13 | Dec ' 12 | Dec ' 11 | Dec ' 10 | |
|---|---|---|---|---|---|
| Sales | 6,864.94 | 5,612.92 | 6,303.54 | 7,690.12 | 5,672.10 |
| Operating profit | -324.48 | -286.82 | 460.49 | 1,255.00 | 1,232.88 |
| Interest | 547.05 | 436.20 | 296.98 | 603.56 | 54.19 |
| Gross profit | -86.71 | -574.71 | 403.10 | 997.70 | 1,539.01 |
| EPS (Rs) | -20.76 | -42.00 | -3.84 | -72.32 | 27.28 |
Annual
results in details
| Mar ' 14 | Dec ' 13 | Dec ' 12 | Dec ' 11 | Dec ' 10 | |
|---|---|---|---|---|---|
| Other income | 784.82 | 148.32 | 239.60 | 346.26 | 360.33 |
| Stock adjustment | -175.12 | -178.41 | -49.25 | -135.72 | -161.43 |
| Raw material | 2,065.33 | 1,670.46 | 1,528.66 | 1,885.10 | 1,680.31 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 1,274.73 | 1,048.45 | 1,019.59 | 864.79 | 776.14 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 4,024.49 | 3,359.24 | 3,344.05 | 3,820.96 | 2,144.20 |
| Provisions made | - | - | - | - | - |
| Depreciation | 280.17 | 230.19 | 186.16 | 274.08 | 228.35 |
| Taxation | 30.57 | - | -1.94 | 3.38 | 416.52 |
| Net profit / loss | -879.00 | -1,776.85 | -162.34 | -3,052.05 | 1,148.73 |
| Extra ordinary item | -481.54 | -971.96 | -381.23 | -3,772.29 | 254.59 |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 211.66 | 211.55 | 211.46 | 211.00 | 210.52 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | 1487.74 | 1480.02 | 1452.39 | 1458.28 | 1459.97 |
| Agg.of non promotoholding (%) | 35.11 | 34.93 | 34.34 | 34.56 | 34.68 |
| OPM (%) | -4.73 | -5.11 | 7.31 | 16.32 | 21.74 |
| GPM (%) | -1.13 | -9.98 | 6.16 | 12.41 | 25.51 |
| NPM (%) | -11.49 | -30.84 | -2.48 | -37.98 | 19.04 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis